+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Beta Cells"

Type 1 Diabetes - Epidemiology Forecast to 2029 - Product Thumbnail Image

Type 1 Diabetes - Epidemiology Forecast to 2029

  • Report
  • March 2021
  • 43 Pages
  • Global
From
Disease Analysis: Type 1 Diabetes - Product Thumbnail Image

Disease Analysis: Type 1 Diabetes

  • Report
  • May 2021
  • 87 Pages
  • Global
  • 12 Results (Page 1 of 1)
Loading Indicator

Beta cells are a type of cell found in the pancreas that produce and secrete insulin. They are a key component of the endocrine system, responsible for regulating glucose levels in the body. Beta cells are responsible for the production of insulin, which is essential for the metabolism of carbohydrates, fats, and proteins. When the body's glucose levels rise, beta cells release insulin, which helps to move glucose from the bloodstream into the cells, where it can be used for energy. When glucose levels drop, beta cells stop producing insulin. Beta cells are also involved in the production of other hormones, such as glucagon and somatostatin. These hormones help to regulate the body's metabolism and energy levels. In addition, beta cells are involved in the production of amylin, which helps to regulate the release of glucose from the liver. The Beta Cells market is an important part of the Endocrinology industry. It is a rapidly growing market, driven by the increasing prevalence of diabetes and other endocrine disorders. Companies in this market are focused on developing treatments and therapies for diabetes and other endocrine disorders, as well as developing new technologies to improve the diagnosis and management of these conditions. Some companies in the Beta Cells market include Novo Nordisk, Eli Lilly, Sanofi, Merck, and AstraZeneca. Show Less Read more